Florida Senate - 2014                                    SB 1014
       
       
        
       By Senator Garcia
       
       
       
       
       
       38-00556-14                                           20141014__
    1                        A bill to be entitled                      
    2         An act relating to pharmacy benefit managers; creating
    3         s. 465.1862, F.S.; defining terms; specifying contract
    4         terms that must be included in a contract between a
    5         pharmacy benefit manager and a pharmacy; providing
    6         restrictions on the inclusion of prescriptions drugs
    7         on a list that specifies the maximum allowable cost
    8         for such drugs; requiring the pharmacy benefit manager
    9         to disclose certain information to a plan sponsor;
   10         requiring a contract between a pharmacy benefit
   11         manager and a pharmacy to include an appeal process;
   12         requiring a pharmacy benefit manager to contractually
   13         commit to providing a certain reimbursement rate for
   14         generic drugs; providing an effective date.
   15          
   16  Be It Enacted by the Legislature of the State of Florida:
   17  
   18         Section 1. Section 465.1862, Florida Statutes, is created
   19  to read:
   20         465.1862 Pharmacy benefit managers.—
   21         (1) As used in this section, the term:
   22         (a) “Average wholesale price” (AWP) means the published or
   23  suggested cost of pharmaceuticals charged to a pharmacy by a
   24  large group of pharmaceutical wholesalers.
   25         (b) “AWP Discount,” also known as the generic effective
   26  rate, means the negotiated amount a plan sponsor pays to
   27  pharmacies for the ingredient cost of a prescription and
   28  commonly expressed as a percentage of AWP.
   29         (c) “Maximum allowable cost” (MAC) means the upper limit or
   30  maximum amount that an insurance or managed care plan will pay
   31  for generic, or brand-name drugs that have generic versions
   32  available, which are included on a PBM-generated list of
   33  products.
   34         (e) “Plan sponsor” means an employer, insurer, managed care
   35  organization, prepaid limited health service organization,
   36  third-party administration, or other entity contracting for
   37  pharmacy benefit manager services.
   38         (d) “Pharmacy benefit manager” (PBM) means a person,
   39  business, or other entity that provides administrative services
   40  related to processing and paying prescription claims for
   41  pharmacy benefit and coverage programs. Such services may
   42  include contracting with a pharmacy or network of pharmacies;
   43  establishing payment levels for provider pharmacies; negotiating
   44  discounts and rebate arrangements with drug manufacturers;
   45  developing and managing prescription formularies, preferred drug
   46  lists, and prior authorization programs; assuring audit
   47  compliance; and providing management reports.
   48         (2) A pharmacy benefit manager contracting with pharmacies
   49  in this state shall annually contract with a pharmacy on or
   50  before January 1 of the contract year. Such contract must:
   51         (a) Include the basis of the methodology and sources used
   52  to determine the MAC pricing administered by the pharmacy
   53  benefit manager, update the pricing information on such a list
   54  at least every 7 calendar days, and establish a reasonable
   55  process for the prompt notification of such pricing updates to
   56  network pharmacies; and
   57         (b) Maintain a procedure to eliminate products from the
   58  list or modify the MAC pricing in a timely fashion in order to
   59  remain consistent with pricing changes in the marketplace.
   60         (3) In order to place a particular prescription drug on a
   61  MAC list, the pharmacy benefit manager must, at a minimum,
   62  ensure that:
   63         (a) The drug has at least three or more nationally
   64  available, therapeutically equivalent, multiple-source generic
   65  drugs that have a significant cost difference;
   66         (b) The products are listed as therapeutically and
   67  pharmaceutically equivalent or “A” rated in the United States
   68  Food and Drug Administration’s most recent version of the Orange
   69  Book; and
   70         (c) The product is available for purchase without
   71  limitations by all pharmacies in the state from national or
   72  regional wholesalers and may not be obsolete or temporarily
   73  unavailable.
   74         (4) The pharmacy benefit manager must disclose the
   75  following to the plan sponsor:
   76         (a) The basis of the methodology and sources used to
   77  establish applicable MAC pricing in the contract between the
   78  pharmacy benefit manager and the plan sponsor. Applicable MAC
   79  lists must be updated and provided to the plan sponsor whenever
   80  there is a change.
   81         (b) Whether the pharmacy benefit manager uses a MAC list
   82  for drugs dispensed at retail but does not use a MAC list for
   83  drugs dispensed by mail order in the contract between the
   84  pharmacy benefit manager and the plan sponsor or within 21
   85  business days after implementation of the practice.
   86         (c) Whether the pharmacy benefit manager is using the
   87  identical MAC list with respect to billing the plan sponsor as
   88  it does when reimbursing all network pharmacies. If multiple MAC
   89  lists are used, the pharmacy benefit manager must disclose any
   90  difference between the amount paid to a pharmacy and the amount
   91  charged to the plan sponsor.
   92         (5) All contracts between a pharmacy benefit manager and a
   93  contracted pharmacy must include:
   94         (a) A process for appealing, investigating, and resolving
   95  disputes regarding MAC pricing. The process must:
   96         1. Limit the right to appeal to 90 calendar days following
   97  the initial claim;
   98         2. Investigate and resolve the dispute within 7 days; and
   99         3. Provide the telephone number at which a network pharmacy
  100  may contact the pharmacy benefit manager and speak with an
  101  individual who is responsible for processing appeals.
  102         (b) If the appeal is denied, the pharmacy benefit manager
  103  shall provide the reason for the denial and identify the
  104  national drug code of a drug product that may be purchased by a
  105  contracted pharmacy at a price at or below the MAC.
  106         (c) If an appeal is upheld, the pharmacy benefit manager
  107  shall make an adjustment retroactive to the date of
  108  adjudication. The pharmacy benefit manager shall make the
  109  adjustment effective for all similarly situated pharmacies in
  110  this state which are within the network.
  111         (6) A pharmacy benefit manager shall contractually commit
  112  to providing a particular aggregate average reimbursement rate
  113  for generics or a maximum average AWP discount on multi-source
  114  generics as a whole. For the purposes of the AWP discount
  115  amount, a pharmacy benefit manager must use an AWP published by
  116  a nationally available compendia. The aggregate average rate for
  117  reimbursement shall be calculated using the actual amount paid
  118  to the pharmacy, excluding the dispensing fee. The reimbursement
  119  rate may not be calculated solely according to the amount
  120  allowed by the plan and must include all generics dispensed,
  121  regardless of whether they are subject to MAC pricing.
  122         Section 2. This act shall take effect July 1, 2014.